Lyell Immunopharma has entered a definitive agreement to acquire ImmPACT Bio, a privately-owned clinical-stage biotechnology ...

A high level of lymphocytes (white blood cells that recognize something as foreign to the body) can be an indication of ...

Tevogen is driven by a team of experienced industry leaders and scientists with drug development and global product launch experience. Tevogen’s leadership believes that accessible personalized ...

The main populations of lymphocytes are B cells, T cells and natural killer (NK) cells. They are typically (although not exclusively) associated with adaptive immune responses. Populations of ...

The deal will give Lyell a dual-targeting CAR-T candidate for blood cancers. Relatedly, Lyell will also end development of ...

Lymphoproliferative disorders are a group of diseases characterized by the uncontrolled production of white blood cells called lymphocytes, according to Healthline. T-cell disorders include ...

Tevogen is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen’s leadership believes that ...

研究人员利用流式细胞术、免疫印迹及一系列功能实验验证了敲除AMBRA1能够降低FAS蛋白表达，抑制FAS途径诱导的T细胞凋亡。进一步的机制探究中，研究人员利用OPP掺入结合点击化学，蔗糖梯度离心分离核糖体及其结合的mRNA等手段，发现AMBRA1促进 ...

A study reveals a mechanism that controls B-lymphocyte maturation, with SIRT7 playing a critical role. This insight could ...

New platform that closely mimics nature enhances CAR-T cell therapy and transforms immune cells into cancer-fighting ...

Researchers conducted a subgroup analysis of POSEIDON trial data, then characterized underlying biologic mechanisms using mouse models.

South San Francisco, California Saturday, October 26, 2024, 18:00 Hrs [IST] ...